Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Reset

Results: 1640 (Showing 41 to 60) — Export these results

Name Principal Investigator Institution Study Date Approved Project ID
A Machine Learning Approach to Bladder Cancer Screening and Cancer Grade/Stage Differentiation Herbert Chase The Trustees of Columbia University in the City of New York PLCO Mar 16, 2020 PLCO-597
Association of colorectal polyps with dietary inflammation during screening colonoscopy in Men and Women Bhaumik Brahmbhatt Mayo Clinic PLCO Mar 16, 2020 PLCO-593
Risk Prediction Model for Endometrial Cancer using multiple Machine Learning Algorithms and Meta-Analysis Denis Mihaies Brunel Univeristy PLCO Mar 16, 2020 PLCO-590
Autoencoder for CT images and automatic clustering of patients michael roberts Astrazeneca NLST Mar 10, 2020 NLST-647
Similar Patient Search for Cancer Patients Elham Taghizadeh Fraunhofer MEVIS: Institute for Digital Medicine NLST Mar 10, 2020 NLST-645
Interpretable Artificial Intelligence to select patients that will benefit from lung cancer screening Jean-Emmanuel Bibault Stanford University PLCO Mar 5, 2020 PLCO-594
Lung Cancer Detection and Classification Using Deep Learning Daniel Korat Interdisciplinary Center Herzliya NLST Mar 3, 2020 NLST-643
Relationship Among Energy Balance, Health Outcome, and 24-hour Time-Use Lifestyle Behaviors Yaozong He University of Illinois at Urbana-Champaign IDATA Mar 2, 2020 IDATA-34
Interpretable Graph Convolutional Networks with CPC features for Whole Slide Histology Classification Faisal Mahmood Brigham and Women's Hospital NLST Feb 28, 2020 NLST-592
Personalizing colorectal treatment strategies through machine learning Jean-Emmanuel Bibault Stanford University PLCO Feb 27, 2020 PLCO-592
Treatment effect on the Survival Time of Lung Cancer Patients Jing Zhou Department of Family and Preventive Medicine PLCO Feb 27, 2020 PLCO-591
Lung cancer prognosis in CNUH Vi Vo Thi Tuong Chonnam National University NLST Feb 24, 2020 NLST-640
Development and Investigation of Class Imbalanced Data Methods for Lung Cancer Incidence Prediction Using Clinical and Radiomics Data Matloob Khushi The University of Sydney NLST Feb 24, 2020 NLST-641
Imaging Biomarkers for Lung Cancer Screening Hengyong Yu University of Massachusetts Lowell NLST Feb 19, 2020 NLST-639
Evaluation of Thoracic Aortic Aneurysm Mortality with Low-Dose Computed Tomographic Screening. A Claire Watkins Stanford University NLST Feb 19, 2020 NLST-638
Improve Lung Cancer Prediction by Training Multi-task Self-supervised Pre-training on Large Unlabeled Data Yi Chen ASUS AICS NLST Feb 19, 2020 NLST-637
A Machine Learning Approach to Diagnosing Breast Cancer Michele La Ferla University of Malta PLCO Feb 19, 2020 PLCOI-585
Developing a metabolite-based biomarker panel for prostate cancer detection and prognosis in African-American men Arun Sreekumar Baylor College of medicine PLCO Feb 19, 2020 PLCO-583
Second-hand smoke (SHS) and mortality in never-smoking women Neal Freedman NCI PLCO Feb 19, 2020 PLCO-586
A new mathematical model for the computation of optimal cancer surveillance schedules Johannes Reiter Stanford University NLST Feb 7, 2020 NLST-636